TS-075845 — Drug discovery, biologics development, cell therapy research, and advanced in vitro testing all rely on large numbers of cell-based experiments. While continuous perfusion can improve biological relevance by maintaining nutrient availability, removing waste products, and better mimicking physiolog…

TS-075637 — Microfluidic and organ-on-chip platforms are gaining importance in drug discovery, toxicity testing, diagnostics, and advanced biological research. However, widespread adoption remains constrained by the difficulty of connecting microscale devices to conventional fluid delivery hardware. Existing …

TS-071982 — The Need Current microfluidic systems for long-term perfusion rely heavily on syringe or peristaltic pumps, which are costly, bulky, and require external power and technical expertise. These limitations hinder scalability, accessibility, and usability, especially in resource-limited settings. There …